Riskpilot← Back to searchSign inGet full accessSyn & Ergonomi ApS
APSActiveCVR 35635955Gl Vejlevej 59Retail sale of medical and orthopaedic goods · NACE 4774Est. 20144 employees
Revenue 2024
DKK 3,5M
0% vs 2023
EBITDA margin
48.6%
-13% vs 2023
Equity ratio
65.0%
Financial strength
Net profit 2024
DKK 1,3M
-12% vs 2023
| Revenue | DKK 3,5M | +0% |
| EBITDA | DKK 1,7M | -13% |
| Net profit | DKK 1,3M | -12% |
| Total assets | DKK 4,5M | +32% |
| Equity | DKK 2,9M | +39% |
| Employees | 4 | — |
Legal name
Syn & Ergonomi ApS
CVR number
35635955
Legal form
Anpartsselskab
NACE code
4774 · Retail sale of medical and orthopaedic goods
Founded
9. januar 2014
Share capital
DKK 80.000
Employees
4 (FTE)
VAT registered
Yes
Audit selected
Yes
Last report
2024-12-31
Financial year
January – December
Signatory rights
Selskabet tegnes af en direktør.
Company purpose
Selskabets formål er handel med udstyr indenfor dental- og midicoområdet og dermed beslægtet virksomhed.
Address
Gl Vejlevej 59
Phone
+4575895711
Email
info@syn-ergo.dk
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 916 | 1.297 | 963 | 1.404 | 1.579 | 1.346 | 1.583 | 2.531 | 2.223 | 3.505 | 3.492 |
| Staff expenses | -1.413 | -1.485 | -713 | -675 | -1.050 | -937 | -978 | -1.172 | -1.208 | -1.564 | -1.796 |
| EBITDA | -497 | -187 | 250 | 729 | 529 | 409 | 605 | 1.284 | 993 | 1.941 | 1.697 |
| Depreciation & amort. | -28 | -1 | -8 | -16 | -14 | -5 | -34 | -27 | -17 | -0 | -0 |
| EBIT | -525 | -188 | 242 | 714 | 515 | 404 | 571 | 1.257 | 975 | 1.941 | 1.697 |
| Net financials | -14 | -17 | -30 | -2 | -1 | -3 | -3 | -15 | -20 | -1 | 2 |
| Profit before tax | -539 | -206 | 212 | 711 | 513 | 401 | 569 | 1.242 | 955 | 1.940 | 1.698 |
| Tax | -131 | -47 | 48 | 158 | 113 | 89 | 125 | 273 | 210 | 428 | 374 |
| Net profit | -408 | -158 | 165 | 553 | 400 | 312 | 444 | 969 | 744 | 1.512 | 1.324 |
| Item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 834 | 562 | 1.273 | 1.449 | 1.534 | 2.428 | 3.715 | 4.563 | 4.173 | 3.435 | 4.518 |
| Equity | -328 | -486 | -321 | 232 | 632 | 944 | 1.388 | 2.357 | 3.101 | 2.113 | 2.937 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 | 27 | 88 | 0 | 0 | 0 | 0 |
| Short-term debt | 1.162 | 1.048 | 1.591 | 1.214 | 898 | 1.453 | 2.235 | 2.201 | 1.072 | 1.323 | 1.581 |
| Total debt | 1.162 | 1.048 | 1.591 | 1.214 | 898 | 1.480 | 2.323 | 2.201 | 1.072 | 1.323 | 1.581 |
EBITDA margin
48.6%
This company
15.8%
Market median
+208% vs market
20142024
Equity ratio
65.0%
This company
38.2%
Market median
+70% vs market
20142024
Return on equity
45.1%
This company
18.4%
Market median
+145% vs market
20142024
Net profit margin
37.9%
This company
8.1%
Market median
+368% vs market
20142024
Asset turnover
0.77×
This company
1.12×
Market median
-31% vs market
20142024
Debt / equity
0.54×
This company
0.62×
Market median
+13% vs market
20142024
- Annual report 2024Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via CVR / Virk · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via CVR / Virk · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via CVR / Virk · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via CVR / Virk · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via CVR / Virk · Period 2017-01-01 – 2017-12-31
- Annual report 2016Filed via CVR / Virk · Period 2016-01-01 – 2016-12-31
- Annual report 2015Filed via CVR / Virk · Period 2015-01-01 – 2015-12-31
- Annual report 2014Filed via CVR / Virk · Period 2014-01-09 – 2014-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
JR Chief Executive Officer | Chief Executive Officer | 2014 | — | — |
DG Management | Management | 2023 | — | — |
No data on file.
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
Gjerlev Invest Holding ApS | Company | 100.0% | 100.0% | 2023 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Gjerlev Invest Holding ApS
Syn & Ergonomi ApS Board members of Syn & Ergonomi ApS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Jørn Rønvig | Chief Executive Officer | 0 companies |
| Dorte Gjerlev Andersen | Management | 0 companies |